Plus: Moderna’s bird flu vaccine, Obamacare enrollment breaks records, and AstraZeneca’s new breast cancer treatment is FDA approved.…
Moderna stock jumps on AI healthcare prospects…
These are the stocks posting the largest moves in midday trading.…
As Moderna (NASDAQ: MRNA) looks to shore up its business in the wake of its declining coronavirus vaccine sales, its…
…
Exchange-traded funds (ETFs) are great additions to any portfolio. I use them to gain exposure to market segments where I…
Share prices of Moderna (NASDAQ: MRNA) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index.…
Returning 25% in 2024, the S&P 500 delivered a record-breaking year for stock market investors. A resilient global economy coupled…
Moderna stock surges on bird flu vaccine funding…
The U.S. government has awarded Moderna $590 million to advance the late-stage development of its mRNA bird flu vaccine, as…
Although the stock market was having a generally strong week, that isnt the case for vaccine technology company Moderna (NASDAQ:…
Moderna (NASDAQ: MRNA) was one of the hottest companies of early pandemic times, delivering a coronavirus vaccine to market in…
Moderna (NASDAQ: MRNA) shareholders have been having a rough time lately. The biotech stock rocketed higher last spring, but the…
…
New York (www.aktiencheck.de) - Moderna-Aktienanalyse von Morgan Stanley:
Rating und Kursziel
Morgan Stanley-Analyst Terence Flynn senkt das Kursziel für die Aktie von…
A bad seven-month stretch just got worse for Moderna (NASDAQ: MRNA). The messenger RNA (mRNA) pioneer provided a business and…
Shares hit another skid on Jan. 13 when the company cut its guidance for 2024 and 2025.…
All three of the major indexes are moving higher. Investors have been watching inflation reports closely, including the December PPI…
Dow, S&P 500, and Nasdaq futures are rising in premarket trading Tuesday as the stock market digests a report on…
Zum Wochenauftakt schloss der DAX 0,41 Prozent tiefer bei 20.132 Punkten. Heute steht der Leitindex vor Herausforderungen durch gemischte Vorgaben…
The crash in MRNA stock comes after the company slashed its outlook for 2024 and 2025 sales and also announced…
These are the stocks posting the largest moves in midday trading.…
Modernas (NASDAQ: MRNA) sales are slowing down, and Moderna stock is going down -- a lot.
The coronavirus vaccine makers shares…
…
…
Keinen Grund zur Freude haben Inhaber dem Anteilsschein von Moderna : Der Kurs des Papiers sackt kräftig ab. Jahreschart der…
Kulmbach (www.aktiencheck.de) - Moderna-Aktienanalyse von "Der Aktionär":
Thomas Bergmann vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…
Moderna now expects 2025 revenue to come in between $1.5 billion and $2.5 billion, most of which will come in…
Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares plunged almost 20% after the drugmaker pre-announced fiscal 2024 sales below expectations. The company expects...…
Das Unternehmen korrigiert seine Prognose um eine Milliarde Dollar. Grund dafür sind Probleme im Impfstoff-Geschäft. Die Moderna-Aktie gibt am Montag…
Moderna adjusts 2025 revenue outlook, shares fall…
Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow launch of its respiratory syncytial…
…
U.S. equities were mixed at midday, with the Nasdaq losing more than 1% on worries about future Federal Reserve interest-rate…
Die Moderna Aktie zeigt sich zu Beginn des Jahres 2025 in verhaltener Verfassung. Der aktuelle Kurs liegt bei 41,26 EUR,…
The start of a new year is a great time to review what happened over the last 12 months and…
Das Jahr 2024 verlief für die Aktie von Moderna alles andere als erfolgreich. DER AKTIONÄR analysiert, ob dies der Tiefpunkt…
Das Jahr 2024 verlief für die Aktie von Moderna alles andere als erfolgreich. DER AKTIONÄR analysiert, ob dies der Tiefpunkt…
…
Zürich (www.aktiencheck.de) - Moderna-Aktienanalyse von der UBS:
Aktuelle Bewertung
UBS hat das Kursziel für die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN:…
…
…
Zinsen standen gestern im Fokus der Wall Street. Überraschend robuste Konjunkturdaten dämpften die Erwartungen auf Zinssenkungen, was zu Gewinnmitnahmen führte.…
…
U.S. stock futures edge lower after a tech selloff yesterday, investors prepare for a halt to trading tomorrow for the…
Why Moderna shares are rallying this week…
It might seem that valuation is no longer important for investors. Stocks that have sky-high valuation metrics continue to soar.…
Moderna shares soared as investors placed bets that the pharmaceutical giant’s development of an H5N1 bird flu vaccine could boost…
The U.S. stock market experienced a downturn on Tuesday, with the Nasdaq Composite falling by 1.9% and the S&P 500…
Moderna (MRNA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate…